A strong majority of CBD users in Germany report health improvements and few adverse effects, according to a new study published in Frontiers in Pharmacology. Researchers from the University of Freiburg and University of Augsburg conducted an anonymous survey to explore why people are using over-the-counter CBD products and what effects they experience. The survey, …
Category: Cannabis Studies
Peer-reviewed studies covering cannabis and cannabis compounds.
Study: Cannabidiol (CBD) and Cannabidivarin (CBDV) Found to Kill Fungal Pathogens, Including Cryptococcus and Dermatophytes
New research shows that the cannabinoids CBD and CBDV have potent antifungal effects, including the ability to kill Cryptococcus neoformans and prevent biofilm formation. A study published in PLOS Neglected Tropical Diseases has found that cannabidiol (CBD) and cannabidivarin (CBDV) possess significant antifungal properties, particularly against the fungal pathogen Cryptococcus neoformans. Conducted by researchers from …
Johns Hopkins Launches First-Ever Psilocybin Trial for Stroke Recovery
Johns Hopkins University is launching a groundbreaking clinical trial exploring whether psilocybin-assisted therapy can help stroke survivors regain motor function—even years after their injury. The study is part of a new agreement between Johns Hopkins and Rose Hill Life Sciences, a company that holds exclusive rights to intellectual property surrounding psilocybin-based treatments for neurological damage. …
Study: CBD-Enriched Oil Found Effective in Treating Drug-Resistant Epilepsy in Children Over 12-Month Period
A large-scale study conducted across 19 universities and hospitals in Thailand, along with the Ministry of Public Health, found that medical-grade cannabidiol (CBD)-enriched oil significantly reduced seizures in children with drug-resistant epilepsy, with most patients tolerating the treatment for over a year. The prospective observational study followed 101 pediatric patients between 2021 and 2023. Participants …
Study: Cannabis-Based Treatments Associated With Seizure Freedom in Drug-Resistant Epilepsy Patients
A new case series published in the journal Frontiers in Neuroscience details how cannabis-based products led to seizure freedom in nearly a dozen pediatric and adult patients with drug-resistant epilepsy (DRE). Conducted by researchers at the University of Toronto and University Health Network, the retrospective study evaluated 19 patients with DRE—15 of them children—who experienced …
Study: Combination of CBD and Hydroxychloroquine Found Safe and Bioavailable in Phase I Trial
A phase I clinical trial has found that a novel combination of cannabidiol (CBD) and hydroxychloroquine (HCQ), known as IHL-675 A, is well tolerated and bioavailable in healthy volunteers, supporting further investigation in inflammatory conditions such as rheumatoid arthritis. The trial involved 36 participants who were randomly assigned to receive either IHL-675 A, Epidiolex (CBD), …
Study: Aesthetic Elements of Psychedelic Experiences Strongly Linked to Psychological Benefits
A new study finds that the aesthetic quality of psychedelic experiences—such as vivid visual imagery and emotional beauty—may be a key factor in promoting therapeutic benefits. Researchers at the University of Colorado surveyed 96 individuals who had used classic psychedelics like psilocybin, LSD, DMT, or mescaline within the past year. Participants completed several psychological assessments, …
Study: Strong Majority of Psychiatric Patients Open to Psilocybin Therapy, Including Non-Hallucinogenic Options
A majority of psychiatric patients support the idea of psilocybin therapy, with many showing a willingness to try non-hallucinogenic forms, according to new research published in the Journal of Psychoactive Drugs. The study, conducted by researchers at Wright State University, surveyed patients aged 18 to 65 at a community mental health center to assess their …
Study: CBD Reduces Seizures and Brain Damage in Post-Traumatic Epilepsy Model
A new study published in the Journal of Ethnopharmacology finds that cannabidiol (CBD) may offer protective and anticonvulsant effects in cases of post-traumatic epilepsy (PTE). Researchers from Hunan University of Medicine and Ningxia Medical University in China conducted the study using a rat model of PTE triggered by ferric chloride (FeCl₃), including genetically modified rats …
Study: Cannabis Extract Reduces Inflammation in Human Skin Cells More Effectively than CBD Alone
A standardized cannabis extract significantly reduces inflammation in human skin cells—more effectively than CBD alone—according to a new study published in Pharmaceuticals. Researchers from Università degli Studi di Milano in Italy and Linnea SA in Switzerland analyzed the effects of a Cannabis sativa extract (CSE) with 5% CBD and less than 0.2% THC on human …
